This document discusses HIV in emergency settings and outlines research conducted from 2001 to present on this topic. It begins with assumptions and outlines research conducted on HIV prevalence, the magnitude of the issue, behavioral change and communication, and antiretroviral therapy adherence. It then discusses strategies, policies, and results, including increasing inclusion of refugees in national HIV plans, more refugees accessing antiretroviral therapy, and decreased high-risk sexual behavior. The document also summarizes several studies conducted on HIV prevalence in conflict-affected populations, behavioral surveillance surveys, and antiretroviral adherence.
Spatial Inequities and Health Disparities among American Indians and Alaska Natives
Tommi L. Gaines, DrPH
January 26th, 2018
UCSD HIV & Global Health Round
Spatial Inequities and Health Disparities among American Indians and Alaska Natives
Tommi L. Gaines, DrPH
January 26th, 2018
UCSD HIV & Global Health Round
Daniel Lee, MD
Clinical Professor of Medicine
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
По оценкам программы Организации Объединенных Наций по ВИЧ/СПИД UNAIDS, по количеству инфицированных и по методам борьбы с болезнью Россия занимает место в одном ряду с Центральноафриканской Республикой, Демократической Республикой Конго, Индонезией, Нигерией и Южным Суданом. В этих странах не только постоянно увеличивается и без того большое число инфицированных, но они также испытывают недостаток в антиретровирусных препаратах.
Dr. Kathleen Brady of Philadelphia's AIDS Activities Coordinating Office (AACO) gave this presentation at the January 9, 2013 Comprehensive Planning Committee meeting.
Michael Tang, MD
Infectious Disease Fellow
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
Address by president Cyril Ramaphosa on South Africa’s response to the corona...SABC News
It is exactly 10 weeks since we declared a national state of disaster in response to the coronavirus pandemic.
Since then, we have implemented severe and unprecedented measures – including a nation-wide lockdown – to contain the spread of the virus.
The Real World: One Health - zoonoses, ecosystems and wellbeingNaomi Marks
Opening keynote presentation by Professor Jeremy Farrar, Director, Wellcome Trust, at the One Health for the Real World: zoonoses, ecosystems and wellbeing symposium, London 17-18 March 2016
Presented by Eric Fèvre at a Government of Kenya meeting on the development of national brucellosis and anthrax guidelines, Nakuru, Kenya, 26-28 June 2013.
Leandro Mena, MD, MPH
Chair and Professor of Population Health Science
Department of Population Health Science
University of Mississippi Medical Center
Daniel Lee, MD
Clinical Professor of Medicine
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
По оценкам программы Организации Объединенных Наций по ВИЧ/СПИД UNAIDS, по количеству инфицированных и по методам борьбы с болезнью Россия занимает место в одном ряду с Центральноафриканской Республикой, Демократической Республикой Конго, Индонезией, Нигерией и Южным Суданом. В этих странах не только постоянно увеличивается и без того большое число инфицированных, но они также испытывают недостаток в антиретровирусных препаратах.
Dr. Kathleen Brady of Philadelphia's AIDS Activities Coordinating Office (AACO) gave this presentation at the January 9, 2013 Comprehensive Planning Committee meeting.
Michael Tang, MD
Infectious Disease Fellow
Division of Infectious Diseases and Global Public Health
Department of Medicine
University of California, San Diego
Address by president Cyril Ramaphosa on South Africa’s response to the corona...SABC News
It is exactly 10 weeks since we declared a national state of disaster in response to the coronavirus pandemic.
Since then, we have implemented severe and unprecedented measures – including a nation-wide lockdown – to contain the spread of the virus.
The Real World: One Health - zoonoses, ecosystems and wellbeingNaomi Marks
Opening keynote presentation by Professor Jeremy Farrar, Director, Wellcome Trust, at the One Health for the Real World: zoonoses, ecosystems and wellbeing symposium, London 17-18 March 2016
Presented by Eric Fèvre at a Government of Kenya meeting on the development of national brucellosis and anthrax guidelines, Nakuru, Kenya, 26-28 June 2013.
Leandro Mena, MD, MPH
Chair and Professor of Population Health Science
Department of Population Health Science
University of Mississippi Medical Center
NATIONAL AIDS CONTROL PROGRAM
1992- - NACP 1 launched to show down the spread of HIV infection
- national AIDS control board constituted
- NACO setup
1999- - NACP 2 begins focusing on behaviour change , increased decentralization and NGO involvement.
- state AIDS control societies developed .
2002- - national AIDS control policy adopted.
- national blood policy adopted.
2004- - antiretroviral treatment initiated .
2006- - national council on AIDS constituted under chairmanship of prime minister.
- national policy on paediatric ART formulated.
2007- - NACP 3 launched for years (2007-2012)
2012- - NACP 4 launched for next 5 years
e632 www.thelancet.comhiv Vol 6 September 2019ViewpoiAlyciaGold776
e632 www.thelancet.com/hiv Vol 6 September 2019
Viewpoint
The disconnect between individual-level and population-level
HIV prevention benefits of antiretroviral treatment
Stefan Baral, Amrita Rao, Patrick Sullivan, Nancy Phaswana-Mafuya, Daouda Diouf, Greg Millett, Helgar Musyoki, Elvin Geng, Sharmistha Mishra
In 2019, the HIV pandemic is growing and soon over 40 million people will be living with HIV. Effective population-
based approaches to decrease HIV incidence are as relevant as ever given modest reductions observed over the past
decade. Treatment as prevention is often heralded as the path to improve HIV outcomes and to reduce HIV
incidence. Although treatment of an individual does eliminate onward transmission to serodifferent partners
(unde tectable=untransmittable or U=U), population-level observational and experimental data have not shown a similar
effect with scale-up of treatment on reducing HIV incidence. This disconnect might be the result of little attention given
to heterogeneities of HIV acquisition and transmission risks that exist in people at risk for and living with HIV, even in
the most broadly generalised epidemics. Available data suggest that HIV treatment is treatment, HIV prevention is
prevention, and specificity of HIV treatment approaches towards people at highest risk of onward transmission drives
the intersection between the two. All people living with HIV deserve HIV treatment, but both more accurately estimating
and optimising the potential HIV prevention effects of universal treatment approaches necessitates understanding who
is being supported with treatment rather than a focus on treatment targets such as 90-90-90 or 95-95-95.
Introduction
In 2019, we are at a pivotal time in the global HIV response
in that many people believe that the HIV pandemic is
over given the advances in HIV treatment.1 Yet the HIV
pandemic continues to grow as defined by numbers of
people living with HIV. Specifically, given the encouraging
decreases in overall mortality among people living with
HIV, in the context of universal treat ment as prevention,
approximately 930 000 more people annually (1·7 million
new infections minus 770 000 deaths of people living with
HIV) require anti retroviral therapy (ART) and many more
would need to change ART regimens. At the current rate
of new infections, over 40 million people will be living
with HIV by 2025.2 The global optimism about the HIV
pandemic has not been matched by decreases in new
HIV infections. New infections have declined by less than
2% per year since 2005, which means that between
1·8 and 2·5 million people acquired HIV in 2017.2,3 To
date, just over 60% of the 37·9 million people living with
HIV are on ART; of those 37·9 million, just over half
(20·1 million) are estimated to have achieved viral sup
pression.2 Taken together, these data suggest that an
estimated 18 million people living with HIV require ART
or improved ART regimens giv ...
Dr. Kathleen Brady of Philadelphia's AIDS Activities Coordinating Office (AACO) gave this presentation at the January 9, 2013 Comprehensive Planning Committee meeting.
NIH AIDS Executive Committee (NAEC) FY 2019 Ending the HIV Epidemic (EHE) in ...HopkinsCFAR
The NIH Office of AIDS Research (OAR) is pleased to release the NIH AIDS Executive Committee (NAEC) FY 2019 Ending the HIV Epidemic (EHE) in the U.S. Report.
NIMH funding on PrEP use Among Adolescent Girls and Young Women in sub-Sahara...HopkinsCFAR
Dr. Susannah Allison. Dr. Allison is a Program Officer at the National Institute of Mental Health within the Division of AIDS Research. She oversees a portfolio of research focused on the prevention of HIV infection among infants, children, and adolescents as well as research to enhance health outcomes among youth living with HIV. She is also the training director for the division. Prior to working at NIMH, Dr. Allison worked with children and families infected and affected by HIV in Baltimore, Miami, and Washington, DC. She completed her doctorate at George Washington University where she received her Ph.D. in Clinical Child Psychology with an emphasis in child health psychology.
High Sensitivity HIV Testing and Translational Science around PrEPHopkinsCFAR
Joanne Stekler, MD MPH
Associate Professor, Department of Medicine
University of Washington
Inter-Center for AIDS ResearchAntiretroviralsfor Prevention Working Group
November 13, 2017
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
HIV in Emergencies: From research to strategies, policies and results
1. HIV in Emergencies
Paul Spiegel MD,MPH
Deputy Director, DPSM
United Nations High Commissioner
for Refugees
from research to strategies, policies
and results
2001 to present
2. Outline of Presentation
• Assumptions
• Research
– HIV prevalence
– Magnitude of issue
– Behavourial change and communication
– Antiretroviral therapy (ART) adherence
• Strategies and Policies
• Results
3. UNGASS* 2001
12. “Noting that armed conflicts and natural disasters also
exacerbate the spread of the epidemic;”
75. “By 2003, develop and begin to implement national
strategies….recognizing that populations destabilized by
armed conflict, humanitarian emergencies and natural
disasters, including refugees, internally displaced persons,
and in particular women and children, are at increased risk
of exposure to HIV infection; and where appropriate, factor
HIV/AIDS components into international assistance
programmes;”
* UN General Assembly Special Session (Declaration of Commitment on HIV/AIDS)
4.
5. Spiegel PB, Bennedsen AR, Claass J, et al. Prevalence of HIV infection in conflict-affected and displaced people in seven sub-
Saharan African countries: a systematic review. Lancet 2007;369(9580):2187-95.
7. Mock NB, Duale S, Brown LF, et al. Conflict and HIV: A framework for risk assessment to prevent HIV in
conflict-affected settings in Africa. Emerg Themes Epidemiol 2004;1(1):6.
Overlay bw Conflict and HIV prevalence
8. Strand RT, Fernandes DL, Berstrom S, Andersson S. Unexpected low prevalence of HIV among fertile women in Luanda,
Angola. Does war prevent the spread of HIV? Int J STD AIDS. 2007 Jul;18(7):467-71.
Relation of Armed Conflict and HIV
Seropositivity in sub-Saharan Africa
9. HIV Prevalence by Asylum Country and
Country of Origin by Region
* Weighted means: country of asylum by population size, country of origin by refugee population size
** N refers to countries of asylum with >10,000 refugees
Spiegel PB. HIV/AIDS among conflict-affected and displaced populations: dispelling myths and
taking action. Disasters 2004; 28(3): 322-39.
10. Methodology
Spiegel PB, Bennedsen AR, Claass J, et al. Prevalence of HIV infection in conflict-affected and displaced
people in seven sub-Saharan African countries: a systematic review. Lancet 2007;369(9580):2187-95.
• Refugees: original UNHCR
antenatal care (ANC) sentinel
surveillance data
• Nationals: Nearest ANC
sentinel surveillance data from
UNAIDS and WHO (in-country
and non-conflict surrounding
country)
• Lit search: 7 conflict countries
with 65 original datasets
• Uppsala databased for dates
of conflict
11. Spiegel PB, Bennedsen AR, Claass J, et al. Prevalence of HIV infection in conflict-affected and displaced
people in seven sub-Saharan African countries: a systematic review. Lancet 2007;369(9580):2187-95.
12. Spiegel PB, Bennedsen AR, Claass J, et
al. Prevalence of HIV infection in conflict-
affected and displaced people in seven
sub-Saharan African countries: a
systematic review. Lancet
2007;369(9580):2187-95.
13. Spiegel PB, Bennedsen AR, Claass J, et al. Prevalence of HIV infection in conflict-affected
and displaced people in seven sub-Saharan African countries: a systematic review. Lancet
2007;369(9580):2187-95.
Byumba site,
2002, (host) 6.7%
(95%CI: 4.7-9.4)
Gihembe camp,
2002 (refugee) 1.5%
(95%CI: 0.4-3.8)
Lukole camp, 2003,
(refugee) 1.6%
Kagera region,
2003, (host) 3.7%
14. Limitations
• Different methods to collect data among refugee,
host community and country of origin pop. w/
variable quality of data
• Data for surrounding host pop. or region within
country of origin was not always available;
proxies used
• Comparisons could be biased due to different
contexts and years
• Trend data often unavailable or did not include
same sites
15. Conclusions
1. Individual vulnerabilities and risks exist for
persons affected by conflict; this does not
appear to translate into increased HIV infection
at population (pop) level
• All situations must be examined according to context
2. Refugees often have lower or similar HIV
prevalence to that of host communities;
refugees may be vulnerable to HIV infection
3. Could HIV infection spread more post-conflict?
16. INCREASING RISK:
Behaviour change/coping
mechanisms
Gender-based violence
Transactional sex
Reduction in resources
and services
DECREASING RISK:
Reducing mobility
Slowing of urbanization
Increasing resources
Increased access to
services in host area
HIV prevalence at origin
HIV prevalence in host area
Length of time: conflict, existence of camp
HIV Risk Factors for
Conflict-Affected Populations
Modified from Spiegel PB. HIV/AIDS among Conflict-affected and Displaced
Populations: Dispelling Myths and Taking Action. Disasters 2004;28(3):322-39.
18. Estimates of HIV Burden in Emergencies:
2003, 2005, 2006 and 2013
• Objective:
– Quantify proportion of people living with HIV (PLHIV)
who are affected by emergencies (ERs)
• Methods:
– Country-specific estimates of pop affected by ERs
were developed based on 8 and 11 databases
(2003/05/06 & 2013, respectively)
– Combined with UNAIDS HIV database to estimate
numbers of PLHIV (all years)
19. Lowicki-Zucca M, Spiegel PB, Kelly S, Dehne KL, Walker N, Ghys PD. Estimates of HIV burden in
emergencies. Sex Transm Infect 2008; 84 Suppl 1: i42-i8.
Diagram of Development of
Estimates, 2003, 2005,2006
20. Methods
cont
Lowicki-Zucca M, Spiegel PB, Kelly S,
Dehne KL, Walker N, Ghys PD. Estimates
of HIV burden in emergencies. Sex Transm
Infect 2008; 84 Suppl 1: i42-i8.
Spiegel P, Bennett R, Doraiswamy S,
Karmin S, Kobayashi, A, 2015
(unpublished)
Diagram of Development of Estimates, 2003, 2005,2006
Visual description of Interaction
of Databases, 2013
21. Results
Year # persons affected
by ERs
(millions)[range]
# of PLHIV and
affected by ERs
(millions)[range]
% PLHIV affected
by ERs / overall
PLHIV
2003* 349.5 2.6 [2.0-3.4] 7.9% (1 in 13)
2005* 168 1.7 [1.4-2.1] 5.1% (1 in 20)
2006* 185.5 1.8 [1.3-2.5] 5.4% (1 in 19)
2013+ 314 [295-330] 1.6 [1.2-1.9] 4.5% (1 in 22)
*Lowicki-Zucca M, Spiegel PB, Kelly S, Dehne KL, Walker N, Ghys PD. Estimates of HIV
burden in emergencies. Sex Transm Infect 2008; 84 Suppl 1: i42-i8.
+Spiegel P, Bennett R, Doraiswamy S, Karmin S, Kobayashi, A, 2015 (unpublished)
• For 2013
• 67 million [61-73] (21%) people were displaced
• Majority PLHIV affected by ERs were in Sub
Saharan Africa; 1.3 million [1.0-1.6] (81%)
• 1,000,000 [0.9-1.3] PLHIV not have access to
antiretroviral therapy (ART)
22. Limitations
• Estimates do not represent trends
• Estimating non-displaced persons affected
by ERs is complex
• Numerous overlapping of databases; thus
used [range]
• Duration of ER and length of service
disruption
• National HIV estimates and treatment
coverage applied to areas of ERs
23. Conclusions
• Large numbers of PLHIV affected by ERs;
to ‘get to zero*’ need to address this pop
• Ethical, moral and public health issue
• Concentrate on sub-
Saharan Africa
• Sub-national HIV
estimates and ART
coverage needed
• Now is the time!
* Zero new HIV infections, zero discrimination,
zero AIDS-related deaths
25. Behavioral Surveillance Surveys
(BSS) for Displaced Persons and
Host Communities
• Need to understand knowledge, attitudes and
practices of displaced persons, host communities
and interactions
• Developed standardised BSS w/ displ & post-displ
modules incl core indicators, and methodology
• Undertake in both displaced and host
communities (baseline and follow-up surveys)
26. Description
• BSS undertaken separately among refugees
and surrounding communities in Kenya,
Tanzania and Uganda (Dahab 2013)
– 6 paired sites (11,582 persons; 6,448
baseline in 2004/05, 5.134 follow-up 2010/11
• Analysis of 27 BSS in 10 countries among
displaced persons and hosts (24,219 persons)
bw 2004-2012 (Spiegel 2014)
• Descriptive data analysis and multivariable
logistic regression to identify high risk sex,
displacement and interaction
27. Dahab M, Spiegel PB, Njogu PM, Schilperoord M. Changes in HIV-related behaviours, knowledge and testing
among refugees and surrounding national populations: a multicountry study. AIDS Care 2013; 25(8): 998-1009.
28. Spiegel PB, Schilperoord M, Dahab M. High-risk sex and displacement among refugees and surrounding populations in 10
countries: the need for integrating interventions. AIDS 2014; 28(5): 761-71.
29. Forced Sex
• Prevalence of forced sex was similar in
paired sites, with intimate partner
violence being the most frequent, ranging
bw 1-4.6% in camps and 0.8-3.6% in
communities
• Exception of Nepal (10.8% and 9.8%,
respectively)
Spiegel PB, Schilperoord M, Dahab M. High-risk sex and displacement among refugees and
surrounding populations in 10 countries: the need for integrating interventions. AIDS 2014;
28(5): 761-71.
30. Conclusions
1. Data showed no consistent difference in levels
of risky sexual behavior and there was much
variation among different groups
• Prevention strategies should be targeted in highly
integrated manner for both communities
2. Forced sex among women was similar levels
among refugees and nationals with intimate
partner violence most common
• These findings should reduce stigma and
discrimination against refugees
3. Possible to measure change over time but
difficult to attribute to interventions
32. Methodology
Mendelsohn JB, Schilperoord M, Spiegel P, Ross DA. Adherence to antiretroviral therapy and
treatment outcomes among conflict-affected and forcibly displaced populations: a systematic
review. Conflict and health 2012; 6(1): 9.
33. Results
Mendelsohn JB, Schilperoord M, Spiegel P, et al. Is
forced migration a barrier to treatment success? Similar
HIV treatment outcomes among refugees and a
surrounding host community in Kuala Lumpur,
Malaysia. AIDS Behav 2014; 18(2): 323-34.
Mendelsohn J, Spiegel P, Grant A, Doraiswamy S,
Schilperoord M, Larke N, Burton J, Okonji J, Zeh C,
Muhindo B, Njogu P, Mohammed I, Mukui I, Sondorp E,
Ross D. Similar treatmen outcomes among refugees and
host nationals accessing antiretroviral therapy in a Kenyan
refugee camp.
34. Conclusions
1. Conflict –affected and forcibly displaced
persons had good adherence (87-99%)*
2. ART adherence similar among refugees
and nationals
3. Need for systematic monitoring of
adherence linked to displacement cycle
and context-specific support for
adherence/treatment outcomes
* Not including Malaysia and Kenya study
39. Results
1. Increased inclusion of refugees in HIV
National Strategic Plans
– 48% in 2009 to 87% in 2013
2. Increasing number of refuges on ART
– Access to ART at similar level as nationals
increased from 79% in 2010 to 97% in 2014
– For PMTCT was 95% in 2014
3. Decrease in high risk sex and increased
HIV knowledge and testing
40. Results cont
4. Increased funding for emergencies
5. Increasing awareness of issue and
recognition of need to act
44. AIDS, conflict and the media in Africa:
risks in reporting bad data badly
• Headline: "HIV/AIDS soars in war-torn northern Uganda"
– Reuters. Wallis D, 2004
• Headline: "GUINEA: Refugee influx adds fuel to AIDS crisis
in southeast Guinea“
– IRIN. Guinea, 2004
• "Infection rates are particularly high among vulnerable
groups, such as internally displaced persons (IDPs) and
refugees"
– WN.com. Telemans D: Sudan, 2004
Lowicki-Zucca M, Spiegel P, Ciantia F. AIDS, conflict and the media in Africa:
risks in reporting bad data badly. Emerging themes in epidemiology 2005; 2: 12.
45. Headline: "HIV/AIDS soars in war-torn
northern Uganda"
Reuters. Wallis D, 2004
“The rate of HIV/AIDS infection in northern
Uganda is nearly double that in the rest of the
country….”
UNFPA. Muleme G, 2004
46. HIV Prevalence and Income
Inequality in Africa
Piot P, Greener R, Russell S. Squaring the Circle: AIDS, Poverty, and Human Development. PLoS Med.
2007 Oct; 4(10): e314.
47. HIV and Poverty cont
O’Farrell N. Poverty and HIV in sub-Saharan Africa. Lancet. Feb 2001; 357;636-7.
Pearson
=0.29,
p=0.07
48. HIV Sentinel Surveillance
for Refugees
• Measure pregnant women at ANC clinics
• Work with Gov. authorities, use national
protocols, develop training modules, ensure
supervision
• Ensure quality control: double entry, all
positives and 10% negatives to reference lab
• Find funds- approx. 20-30,000 USD/survey
49. SS cont
Completed:
• Uganda 2004 and 2005
• Dadaab in 2004 and begun in July
• Kakuma 2002; 2006
• Tanzania: 2002, 2003, 2004
• Zambia: 2004
Planned:
• East Sudan – Showak begin Jan/Feb 2007
• Uganda – 4 sites Sep/Oct 2007
• Ethiopia – 5 sites – Dec-06/Jan-07
• Tanzania – 3-4 sites – Dates not confirmed
50.
51.
52. Risk versus vulnerability
• Risk of HIV is the likelihood that a person will become
infected with HIV either due to his or her own actions
(knowingly or not) or due to another person’s action.
Unprotected sex with multiple partners and sharing
contaminated needles are risky activities that increase
the probability of HIV infection.
• Vulnerability to HIV is a person’s or a community’s
inability to control their risk of infection. It may be
attributed, inter alia, to poverty, disempowering gender
roles or migration.
53. Behavioural Surveillance Survey (BSS)
Study: Objective and Methodology
• To evaluate quality of BSS in HEs and
post-conflict situations and provide
recommendations to NGOs and Gov'ts on
how to improve quality
• 31 BSS evaluated between 1998-2005 in
14 countries classified as reproducible if
pop. based sampling:
– Defined sampling frame
– Used probabilistic sampling (incl. PPS
for cluster sampling)
54. The Sphere Project, 2004
• Humanitarian Charter
• Universal minimum
standards in core areas
Aim:
• Quality of assistance
• Accountability
• HIV is cross-cutting
issue
55. Guidelines for HIV Interventions in
Emergency Settings, IASC, 2003 and
2010
• Matrix in 3 phases
– Emergency
Preparedness
– Minimum Response
(to be conducted
even in emerg.)
– Comprehensive
Response
(Stabilised Phase)
By sector/cluster
56. Post-emergency, 2005
1. Integrate refugee
issues into national
HIV programs and
policies
2. Implement sub
regional (cross-border)
initiatives
3. Combine humanitarian
and development
funding
57. Consensus statement
• ART neglected but feasible
• Continuation of ART for
those on treatment
• Initiation of ART for those
meeting minimum req’ts
• Need to scale up PMTCT
• PEP for all exposed HCWs
• PEP and rape mgt for
survivors of rape
Consensus Statement, 2006
58. ART Policy for Refugees, 2007
• Need to scale up PMTCT
• PEP for all occupational and
non occupational exposure
• Continuity of ART is priority
• Initiate if minimum criteria in
place
– Availability of resources
– Sufficiently trained persons
– Protocols
– Confidentiality
– Supervision
– 12 months of funding
– Local population has access
59. Clinical guidelines for antiretroviral
therapy management for displaced
populations, 2007 and 2014
– Continuation
ART with history
– Initiation of ART
– ART continuation
upon return
– Care and support
for PLHIV
60. HIV Assessment in Emergencies,
2007
IDPs
– Comprehensive
Assessment Tool
– Key Informant
Interviews, FGD guides
field tested in 2006 and
2007
– First Global IDP
Consultation in April
2007
– Tools finalized in 2007